SCHEDULE 13G/A
Statement of Beneficial Ownership
Avalo Therapeutics, Inc. Filed Acc 0000919574-26-008106
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Point72 Asset Management, L.P. | 1,625,019 | 3.0% |
| Point72 Capital Advisors, Inc. | 1,625,019 | 3.0% |
| Steven A. Cohen | 1,625,019 | 3.0% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…